Michael Adrian Nazak - Net Worth and Insider Trading

Michael Adrian Nazak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Adrian Nazak owns 2 companies in total, including Aridis Pharmaceuticals Inc (ARDS) , and AN2 Therapeutics Inc (ANTX) .

Click here to see the complete history of Michael Adrian Nazak’s form 4 insider trades.

Insider Ownership Summary of Michael Adrian Nazak

Ticker	Comapny	Transaction Date	Type of Owner
ARDS	Aridis Pharmaceuticals Inc	2020-01-01	Chief Financial Officer
ANTX	AN2 Therapeutics Inc	2022-03-24	Chief Accounting Officer

Michael Adrian Nazak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Adrian Nazak Ownership Network

Ownership Network List of Michael Adrian Nazak

No Data

Ownership Network Relation of Michael Adrian Nazak

Michael Adrian Nazak Owned Company Details

What does Aridis Pharmaceuticals Inc do?

Who are the key executives at Aridis Pharmaceuticals Inc?

Michael Adrian Nazak is the Chief Financial Officer of Aridis Pharmaceuticals Inc. Other key executives at Aridis Pharmaceuticals Inc include director & 10 percent owner & CEO & CSO & Director Vu Truong , director & 10 percent owner Eric Patzer , and 10 percent owner Fibrosis Foundation Cystic .

Aridis Pharmaceuticals Inc (ARDS) Insider Trades Summary

Over the past 18 months, Michael Adrian Nazak made no insider transaction in Aridis Pharmaceuticals Inc (ARDS). Other recent insider transactions involving Aridis Pharmaceuticals Inc (ARDS) include a net purchase of 714,286 shares made by Eric Patzer , and a net purchase of 714,286 shares made by Vu Truong .

In summary, during the past 3 months, insiders sold 0 shares of Aridis Pharmaceuticals Inc (ARDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aridis Pharmaceuticals Inc (ARDS) were sold and 1,428,572 shares were bought by its insiders, resulting in a net purchase of 1,428,572 shares.

Aridis Pharmaceuticals Inc (ARDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aridis Pharmaceuticals Inc Insider Transactions

No Available Data

Michael Adrian Nazak Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Adrian Nazak. You might contact Michael Adrian Nazak via mailing address: 5941 Optical Court, San Jose Ca 95138.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.